Trademarkia Logo

Canada

C$
Trademark Search in Canada
Bio City

View On IC.GC.CA

Bio City
FORMALIZED

on 18 Jun 2025

Last Applicant/ Owned by

UAB "Northway turto valdymas"

S. Žukausko g. 21-43LT-08234 Vilnius

LT

Serial Number

2406225 filed on 21st Mar 2025

Bio City

Trademark usage description

pharmaceutical preparations, namely, for the treatment of oncological, cardiovascular, respiratory, inflammatory, autoimmune and degenerative diseases Read More

Vienna Information

1 . 13 . 1

Armillary spheres, planetaria, astronomic orbits, atomic models, molecular modelsSphères armillaires, planétariums, orbites astronomiques, schémas d'atomes, schémas de molécules

1 . 13 . 15

Atomic models, molecular models, representations of human, animal or vegetal cells, images of bacteria or viruses, DNA helixesSchémas atomiques, schémas de molécules, représentations de cellules humaines, animales ou végétales, images de bactéries ou de virus, hélices d'ADN

27 . 3 . 1

Letters or numerals representing a human being or a part of the human body, an animal or a part of an animal's body, a plant, a heavenly body, a natural phenomenon or an objectLettres ou chiffres représentant un être humain ou une partie du corps humain, un animal ou une partie du corps d'un animal, un végétal, un corps céleste, un phénomène naturel ou un objet

27 . 3 . 12

Letters or numerals representing a heavenly body or a natural phenomenonLettres ou chiffres représentant un corps céleste ou un phénomène naturel

Classification Information

Class [005]
Pharmaceutical preparations, namely, for the treatment of oncological, cardiovascular, respiratory, inflammatory, autoimmune and degenerative diseases and disorders, rheumatoid arthritis, multiple sclerosis, allergies and COVID-19; drugs for medical purposes, namely pharmaceutical preparations for the treatment of oncological, cardiovascular, respiratory, inflammatory, autoimmune and degenerative diseases and disorders, rheumatoid arthritis, multiple sclerosis, allergies and COVID-19; biological preparations for medical purposes, namely, for the treatment of oncological, cardiovascular, respiratory, inflammatory, autoimmune and degenerative diseases and disorders, rheumatoid arthritis, multiple sclerosis, allergies and COVID-19; biological tissue cultures for medical purposes, namely, for the treatment of oncological, cardiovascular, respiratory, inflammatory, autoimmune and degenerative diseases and disorders, rheumatoid arthritis, multiple sclerosis, allergies and COVID-19; chemical preparations for medical purposes, namely, for the treatment of oncological, cardiovascular, respiratory, inflammatory, autoimmune and degenerative diseases and disorders, rheumatoid arthritis, multiple sclerosis, allergies and COVID-19.

Classification kind code

12

Class [042]
Scientific and technological services and research and design relating thereto, namely, research and design in the field of products and processes development of biotechnology products and processes; bacteriological research; biological research; chemistry services in the nature of product development and quality control of biotechnology products; chemical research; conducting clinical trials for others; scientific research; medical research; scientific laboratory services; technological research in the field of pharmaceutical studies; technological consultancy in the field of development of manufacturing processes for biotechnology products.

Classification kind code

12

Class [044]
Medical services; alternative medicine services; in vitro fertilization services; occupational therapy services; human tissue bank services; rental of medical equipment; medical analysis services for diagnostic and treatment purposes provided by medical laboratories.

Classification kind code

12

Mark Details

Serial Number

2406225

Mark Type

Trademark

Legal History

Action TakenStatus
Submitted for opposition 257
on 19th Jun 2025		Designation Notification - Madrid Protocol
Submitted for opposition 1
on 18th Jun 2025		Created
Submitted for opposition 31
on 18th Jun 2025		Formalized
Submitted for opposition 30
on 21st Mar 2025		Filed
Submitted for opposition 228
on 21st Mar 2025		International Registration